Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05YFZ
|
|||
Former ID |
DNC010209
|
|||
Drug Name |
9-(2-aminoethyl)-9,10-dihydroanthracene
|
|||
Synonyms |
CHEMBL160893; 9-(2-aminoethyl)-9,10-dihydroanthracene; BDBM35923; 9,10-dihydroanthracene(DHA), 2a
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H17N
|
|||
Canonical SMILES |
C1C2=CC=CC=C2C(C3=CC=CC=C31)CCN
|
|||
InChI |
1S/C16H17N/c17-10-9-16-14-7-3-1-5-12(14)11-13-6-2-4-8-15(13)16/h1-8,16H,9-11,17H2
|
|||
InChIKey |
OWPHKTVZEZNCMB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 2A receptor (HTR2A) | Target Info | Inhibitor | [1] |
Histamine H1 receptor (H1R) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Inflammatory mediator regulation of TRP channels | ||||
Gap junction | ||||
Serotonergic synapse | ||||
Panther Pathway | Histamine H1 receptor mediated signaling pathway | |||
5HT2 type receptor mediated signaling pathway | ||||
Reactome | Histamine receptors | |||
G alpha (q) signalling events | ||||
Serotonin receptors | ||||
WikiPathways | Monoamine GPCRs | |||
GPCRs, Class A Rhodopsin-like | ||||
IL-4 Signaling Pathway | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
SIDS Susceptibility Pathways | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity. Bioorg Med Chem. 2009 Sep 15;17(18):6496-504. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.